Evidence map›Paper›PMID 25658630›Full record

SynthesisPloS one2015

A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction.

Willemien L Verloop, Martine M A Beeftink, Bernadet T Santema, Michiel L Bots, Peter J Blankestijn, Maarten J Cramer, Pieter A Doevendans, Michiel Voskuil

Abstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Article
  7. Article
  8. A Need to Preserve Ejection Fraction during Heart Failure.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Hypertensive Heart Failure.Journal of clinical medicine · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Willemien L VerloopDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Martine M A BeeftinkDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Bernadet T SantemaDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Michiel L BotsThe Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Peter J BlankestijnDepartment of Nephrology, University Medical Center Utrecht, Utrecht, the Netherlands.
Maarten J CramerDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Pieter A DoevendansDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Michiel VoskuilDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure with preserved left ventricular ejection fraction (HFPEF) affects about half of all patients diagnosed with heart failure. The pathophysiological aspect of this complex disease state has been extensively explored, yet it is still not fully understood. Since the sympathetic nervous system is related to the development of systolic HF, we hypothesized that an increased sympathetic nerve activation (SNA) is also related to the development of HFPEF. This review summarizes the available literature regarding the relation between HFPEF and SNA. METHODS AND

resultsElectronic databases and reference lists through April 2014 were searched resulting in 7722 unique articles. Three authors independently evaluated citation titles and abstracts, resulting in 77 articles reporting about the role of the sympathetic nervous system and HFPEF. Of these 77 articles, 15 were included for critical appraisal: 6 animal and 9 human studies. Based on the critical appraisal, we selected 9 articles (3 animal, 6 human) for further analysis. In all the animal studies, isoproterenol was administered to mimic an increased sympathetic activity. In human studies, different modalities for assessment of sympathetic activity were used. The studies selected for further evaluation reported a clear relation between HFPEF and SNA.

conclusionCurrent literature confirms a relation between increased SNA and HFPEF. However, current literature is not able to distinguish whether enhanced SNA results in HFPEF, or HFPEF results in enhanced SNA. The most likely setting is a vicious circle in which HFPEF and SNA sustain each other.

Indexed as

AnimalsDatabases, FactualEchocardiographyHeart FailureHumansSympathetic Nervous SystemVentricular Function, Left

Identifiers

PMID25658630
PMCPMC4319815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.